In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
In the latest session, Precigen Inc (NASDAQ: PGEN) closed at $1.49 down -6.29% from its previous closing price of $1.59. In other words, the price has decreased by -$6.29 from its previous closing price. On the day, 1.87 million shares were traded. PGEN stock price reached its highest trading level at $1.54 during the session, while it also had its lowest trading level at $1.41.
Ratios:
For a deeper understanding of Precigen Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.76 and its Current Ratio is at 4.76. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.07.
On November 18, 2022, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $7.Cantor Fitzgerald initiated its Overweight rating on November 18, 2022, with a $7 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 09 ’24 when Perez Jeffrey Thomas bought 58,823 shares for $0.85 per share. The transaction valued at 50,000 led to the insider holds 743,097 shares of the business.
KIRK RANDAL J bought 23,529,411 shares of PGEN for $19,999,999 on Aug 09 ’24. The Director now owns 64,547,214 shares after completing the transaction at $0.85 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PGEN now has a Market Capitalization of 469102624 and an Enterprise Value of 373934016. For the stock, the TTM Price-to-Sale (P/S) ratio is 111.77 while its Price-to-Book (P/B) ratio in mrq is 11.33. Its current Enterprise Value per Revenue stands at 95.27 whereas that against EBITDA is -4.147.
Stock Price History:
The Beta on a monthly basis for PGEN is 1.66, which has changed by 0.07194245 over the last 52 weeks, in comparison to a change of 0.077997446 over the same period for the S&P500. Over the past 52 weeks, PGEN has reached a high of $2.17, while it has fallen to a 52-week low of $0.65. The 50-Day Moving Average of the stock is -10.06%, while the 200-Day Moving Average is calculated to be 19.70%.
Shares Statistics:
For the past three months, PGEN has traded an average of 2.04M shares per day and 1420360 over the past ten days. A total of 292.87M shares are outstanding, with a floating share count of 162.39M. Insiders hold about 44.77% of the company’s shares, while institutions hold 25.87% stake in the company. Shares short for PGEN as of 1741910400 were 22657367 with a Short Ratio of 11.10, compared to 1739491200 on 19049259. Therefore, it implies a Short% of Shares Outstanding of 22657367 and a Short% of Float of 11.73.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
